Network origin in Jeanne Jew first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
24
| Subsidiary | Pharmaceuticals: Major | 24 |
| Public Company | Biotechnology | 18 | |
| Public Company | Pharmaceuticals: Major | 15 | |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics.
10
| Extinct | Pharmaceuticals: Major | 10 |
| Extinct | Biotechnology | 7 | |
| Public Company | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jeanne Jew via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing General Counsel Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer Director/Board Member Founder President | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Treasurer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor Director/Board Member General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Executive Officer Investor Relations Contact | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director of Finance/CFO Chief Executive Officer Chairman | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Kalobios Pharmaceuticals, Inc. | Chairman Director/Board Member Director/Board Member | ||
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact Director of Finance/CFO | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| Yale School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Synergia Pharma, Inc.
 Synergia Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synergia Pharma, Inc. develops clinical therapeutics. It offers therapeutics for the treatment of migraine and other neurological disorders. The company is headquartered in South San Francisco, CA | Pharmaceuticals: Other | Director/Board Member President | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| University of Virginia | College/University | Doctorate Degree Undergraduate Degree | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree Undergraduate Degree | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| Rensselaer Polytechnic Institute | College/University | Doctorate Degree Doctorate Degree |
Statistics
International
| United States | 47 |
| China | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 3 |
Operational
| Director/Board Member | 416 |
| Corporate Officer/Principal | 193 |
| Independent Dir/Board Member | 146 |
| Chief Tech/Sci/R&D Officer | 71 |
| Undergraduate Degree | 70 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| George Scangos | 33 |
| Thomas Wiggans | 31 |
| Ted Love | 31 |
| Nicole Vitullo | 29 |
| Brigitte Smith | 28 |
| Arlene Morris | 28 |
| Rolf K. Hoffmann | 27 |
| Laura Brege | 27 |
| Timothy Franson | 26 |
| Dennis J. Henner | 26 |
| Leonard Post | 25 |
| George Tidmarsh | 22 |
| Errol de Souza | 21 |
| V. Lawlis | 21 |
- Stock Market
- Insiders
- Jeanne Jew
- Company connections
